IDEXX Laboratories Exceeds Expectations
For the second quarter in a row, animal diagnostics company IDEXX Laboratories (NASDAQ: IDXX) increased its revenue and earnings guidance. While other sectors of the economy are experiencing slower growth, IDEXX's core market -- companion animal diagnostics -- is growing nicely, and the company's 2015 shift to a direct sales model continues to generate impressive sales increases. Let's take a look at the details behind a good quarter of execution.
Continue Reading Below
IDEXX Laboratories has good long term prospects thanks to spending trends on companion animals. Image source: Getty Images.
IDEXX Laboratories second-quarter results: The raw numbers
Starting with the headline numbers:
<3>More From Fool.com
Continue Reading Below
Advertisement Warren Buffett Tells You How to Turn $40 Into $10 Million
LeBron James: The Next Warren Buffett?
Social Security: 3 Things to Know Before Taking Benefits Early
3 Social Security Secrets You Probably Don't Know
A good set of results, and management felt suitably confident enough to raise full-year guidance:
What happened in IDEXX Laboratories' second quarter
Data source: IDEXX Laboratories presentations.
SediVue. Image source: Idexx Laboratories.
Future growth plans
Looking ahead
A secret billion-dollar stock opportunity
The world's biggest tech company forgot to show you something, but a few Wall Street analysts and the Fool didn't miss a beat: There's a small company that's powering their brand-new gadgets and the coming revolution in technology. And we think its stock price has nearly unlimited room to run for early in-the-know investors! To be one of them, just click here
Lee Samahafree for 30 daysconsidering a diverse range of insightsdisclosure policy